Literature DB >> 2065505

An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers.

K Watanabe1, Y Ohkubo, Y Funahashi, T Nishimaki, T Moritoh, R Kasukawa, S Kaise, T Tomita, A Matsukawa.   

Abstract

Rheumatoid factor (RF) is known to be present very frequently in HB virus carriers. When RF was assayed in 140 asymptomatic carriers by agglutination method, 20.0% were found to be positive, whereas 2.7% in the controls (p less than 0.01). ELISA for detection of RF isotypes showed RF in carriers to be almost IgMRF only. IgMRF showed a tendency to react more readily to human IgG rather than to rabbit IgG. The incidence of IgMRF positivity was higher among anti-HBe antibody-positive carriers than among anti-HBe antibody negative ones, but the difference between the two populations was not significant. However, the incidence of IgMRF positivity in the group showing hepatic dysfunctions was found to be significantly higher than in the group with normal hepatic functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065505     DOI: 10.1007/BF02208030

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

1.  Anti-gamma globulin factors in liver disease.

Authors:  L BONOMO; J LOSPALLUTO; M ZIFF
Journal:  Arthritis Rheum       Date:  1963-04

2.  Small and large forms of hepatitis B e antigen in the serum: determination by two-site sandwich radioimmunoassay with monoclonal antibodies.

Authors:  K Baba; I Ise; S Aihara; S Kishimoto; F Tsuda; K Tachibana; Y Miyakawa; M Mayumi
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.

Authors:  F J Dudley; M J O'Shea; S Sherlock
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

4.  The lack of association between rheumatoid factor and hepatitis B antigen.

Authors:  J H Hoofnagle; J A Markenson; C A Daniels; R J Gerety; A L Notkins; L F Barker
Journal:  Am J Med Sci       Date:  1974-07       Impact factor: 2.378

5.  Agglutinating factor in serum of patients with viral hepatitis.

Authors:  A Risemberg; A G De Gomez; U Rife
Journal:  Ann Rheum Dis       Date:  1969-07       Impact factor: 19.103

6.  Rheumatoid factor and Australia antigen in acute and chronic hepatitis.

Authors:  I State; V Runcan; M Voiculescu; D State
Journal:  Rev Roum Med Intern       Date:  1973

7.  Rheumatoid factor and Australia antigen.

Authors:  J F Ziegenfuss; J Miller; D Rossman
Journal:  N Engl J Med       Date:  1971-05-13       Impact factor: 91.245

8.  Anti-e and rheumatoid factor activity in hepatitis B.

Authors:  R S Tedder; M Briggs
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

9.  Identity of antibody to hepatitis B e/1 antigen as an atypical rheumatoid factor.

Authors:  K Anderson-Visoná; V M Villarejos
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

10.  Immunoglobulin class of rheumatoid factors detected by enzyme-linked immunosorbent assay.

Authors:  T Nishimaki; S Watanabe; H Yoshida; R Kasukawa
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

View more
  7 in total

1.  Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome.

Authors:  Ming-Han Chen; Liang-Tsai Hsiao; Ming-Huang Chen; Chang-Youh Tsai; Yi-Hsiang Huang; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2011-08-02       Impact factor: 2.980

2.  Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers.

Authors:  Ediz Dalkılıç; Mustafa Ferhat Öksüz; Ayşe Nur Tufan; Aysun Özbek; Ali Nizamoğlu; Mürside Esra Dolarslan; Belkıs Nihan Coşkun; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2015-03-31

3.  Rheumatoid Factor and Anti-Modified Protein Antibody Reactivities Converge on IgG Epitopes.

Authors:  Aisha M Mergaert; Zihao Zheng; Michael F Denny; Maya F Amjadi; S Janna Bashar; Michael A Newton; Vivianne Malmström; Caroline Grönwall; Sara S McCoy; Miriam A Shelef
Journal:  Arthritis Rheumatol       Date:  2022-04-10       Impact factor: 15.483

Review 4.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

5.  The absence of antibodies to malaria and human immunodeficiency virus, and the presence of hepatitis B surface antigen as diagnostic markers of rheumatoid arthritis.

Authors:  A O Adebajo; B L Hazleman
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

6.  Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection.

Authors:  Sang-il Lee; Wan Hee Yoo; Hee Jin Yun; Dal Sik Kim; Hye Soo Lee; Sam Im Choi; Ji An Hur; Yong Gon Cho
Journal:  Clin Rheumatol       Date:  2006-11-29       Impact factor: 3.650

7.  Chronic hepatitis C virus infection is associated with the development of rheumatoid arthritis: a nationwide population-based study in taiwan.

Authors:  Fu-Hsiung Su; Chien-Sheng Wu; Fung-Chang Sung; Shih-Ni Chang; Chien-Tien Su; Ying-Hua Shieh; Chih-Ching Yeh
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.